Cancer Clinical Trial -HCW Biologics-HCW9218

Cancer

Status:

Open

ClinicalTrials.gov:

NCT05304936

HCW9218 for Advanced Pancreatic Cancer

Drug

HCW9218, Bifunctional TGF-β antagonist/IL-15 protein complex

Phase

Phase I/||

Condition

Advanced Pancreatic Adenocarcinoma

Keywords

TGF-β Antagonist IL-15 Protein Complex